 Fabienne Gally
Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fatty Acid-Binding Proteins | 5 | 2022 | 60 | 2.700 |
Why?
| | TRPM Cation Channels | 2 | 2018 | 73 | 1.380 |
Why?
| | Smoke | 3 | 2017 | 134 | 1.160 |
Why?
| | Pneumonia, Mycoplasma | 4 | 2012 | 42 | 1.140 |
Why?
| | PPAR gamma | 3 | 2022 | 180 | 1.100 |
Why?
| | Mycoplasma pneumoniae | 3 | 2012 | 39 | 1.050 |
Why?
| | Neoplasm Proteins | 2 | 2019 | 445 | 0.990 |
Why?
| | Listeriosis | 2 | 2019 | 64 | 0.920 |
Why?
| | Listeria monocytogenes | 2 | 2019 | 98 | 0.880 |
Why?
| | Immunity, Innate | 6 | 2017 | 758 | 0.860 |
Why?
| | Radiodermatitis | 1 | 2018 | 7 | 0.780 |
Why?
| | Mucin-5B | 1 | 2021 | 164 | 0.760 |
Why?
| | Macrophages | 3 | 2022 | 1338 | 0.730 |
Why?
| | Macrophages, Alveolar | 3 | 2021 | 371 | 0.670 |
Why?
| | Glycoproteins | 3 | 2021 | 350 | 0.660 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 170 | 0.660 |
Why?
| | Inflammation | 4 | 2022 | 2427 | 0.630 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2021 | 371 | 0.610 |
Why?
| | Cytokines | 4 | 2019 | 1974 | 0.610 |
Why?
| | Pneumonia | 3 | 2021 | 557 | 0.580 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 1213 | 0.580 |
Why?
| | Down Syndrome | 1 | 2017 | 291 | 0.520 |
Why?
| | Phosphoproteins | 2 | 2011 | 335 | 0.470 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2013 | 134 | 0.460 |
Why?
| | Pseudomonas Infections | 1 | 2013 | 183 | 0.450 |
Why?
| | Bronchi | 1 | 2013 | 243 | 0.450 |
Why?
| | Pseudomonas aeruginosa | 2 | 2013 | 296 | 0.440 |
Why?
| | Epithelial Cells | 3 | 2017 | 1034 | 0.440 |
Why?
| | Mice, Knockout | 6 | 2021 | 2888 | 0.430 |
Why?
| | Down-Regulation | 1 | 2013 | 681 | 0.410 |
Why?
| | Mice | 15 | 2021 | 15510 | 0.400 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2008 | 34 | 0.390 |
Why?
| | Lung | 6 | 2021 | 3586 | 0.380 |
Why?
| | Mice, Inbred C57BL | 7 | 2018 | 5232 | 0.370 |
Why?
| | Respiratory Hypersensitivity | 1 | 2008 | 82 | 0.360 |
Why?
| | Influenza, Human | 1 | 2013 | 460 | 0.350 |
Why?
| | Toll-Like Receptor 2 | 3 | 2013 | 148 | 0.330 |
Why?
| | Bacterial Load | 2 | 2019 | 62 | 0.320 |
Why?
| | Oxidative Stress | 1 | 2013 | 1237 | 0.310 |
Why?
| | Binding Sites | 2 | 2021 | 1320 | 0.300 |
Why?
| | Cells, Cultured | 7 | 2019 | 4413 | 0.300 |
Why?
| | RNA, Messenger | 3 | 2019 | 2847 | 0.280 |
Why?
| | Animals | 16 | 2021 | 35194 | 0.270 |
Why?
| | DNA-Binding Proteins | 1 | 2011 | 1456 | 0.270 |
Why?
| | Allergens | 1 | 2008 | 487 | 0.260 |
Why?
| | Tobacco | 2 | 2017 | 147 | 0.260 |
Why?
| | Transcription Factors | 1 | 2011 | 1636 | 0.250 |
Why?
| | Enhancer Elements, Genetic | 2 | 2021 | 167 | 0.250 |
Why?
| | Superoxide Dismutase | 2 | 2015 | 346 | 0.240 |
Why?
| | Cell Line | 2 | 2021 | 3013 | 0.240 |
Why?
| | Gene Expression Regulation | 3 | 2022 | 2628 | 0.230 |
Why?
| | Niemann-Pick Disease, Type A | 1 | 2021 | 6 | 0.230 |
Why?
| | Niemann-Pick Disease, Type B | 1 | 2021 | 6 | 0.230 |
Why?
| | Lysophospholipase | 1 | 2021 | 12 | 0.230 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2021 | 24 | 0.230 |
Why?
| | A549 Cells | 1 | 2021 | 57 | 0.220 |
Why?
| | Gain of Function Mutation | 1 | 2021 | 27 | 0.220 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2021 | 50 | 0.220 |
Why?
| | NF-kappa B | 3 | 2019 | 715 | 0.220 |
Why?
| | Chromatin | 2 | 2021 | 432 | 0.210 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2021 | 2029 | 0.200 |
Why?
| | Respiratory Mucosa | 2 | 2012 | 245 | 0.200 |
Why?
| | Th2 Cells | 2 | 2012 | 176 | 0.200 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 502 | 0.200 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 1125 | 0.190 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 199 | 0.190 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2018 | 127 | 0.190 |
Why?
| | Blotting, Western | 2 | 2013 | 1316 | 0.190 |
Why?
| | Receptors, Glucocorticoid | 1 | 2019 | 139 | 0.190 |
Why?
| | Alpha-Globulins | 1 | 2018 | 19 | 0.190 |
Why?
| | RNA Polymerase II | 1 | 2021 | 292 | 0.180 |
Why?
| | Models, Genetic | 1 | 2021 | 659 | 0.170 |
Why?
| | Dexamethasone | 1 | 2019 | 318 | 0.170 |
Why?
| | Mice, Transgenic | 5 | 2018 | 2159 | 0.170 |
Why?
| | Mucociliary Clearance | 2 | 2018 | 38 | 0.170 |
Why?
| | Disease Models, Animal | 3 | 2021 | 3892 | 0.170 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2017 | 141 | 0.170 |
Why?
| | Lipopolysaccharides | 2 | 2018 | 956 | 0.160 |
Why?
| | Hyaluronic Acid | 1 | 2018 | 177 | 0.160 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 490 | 0.160 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2017 | 403 | 0.160 |
Why?
| | Humans | 13 | 2022 | 112249 | 0.160 |
Why?
| | Inflammation Mediators | 1 | 2019 | 555 | 0.150 |
Why?
| | Cell Survival | 1 | 2019 | 1185 | 0.150 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 551 | 0.140 |
Why?
| | Acute Lung Injury | 1 | 2018 | 325 | 0.140 |
Why?
| | Protein Binding | 2 | 2018 | 2112 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2019 | 1244 | 0.130 |
Why?
| | Skin | 1 | 2018 | 694 | 0.130 |
Why?
| | Genetic Predisposition to Disease | 2 | 2021 | 2406 | 0.130 |
Why?
| | Immunoenzyme Techniques | 1 | 2013 | 230 | 0.130 |
Why?
| | Immunoprecipitation | 1 | 2013 | 180 | 0.130 |
Why?
| | Lipid Peroxidation | 1 | 2013 | 160 | 0.120 |
Why?
| | Base Sequence | 1 | 2017 | 2323 | 0.120 |
Why?
| | Ovalbumin | 2 | 2012 | 190 | 0.120 |
Why?
| | Physical Conditioning, Animal | 1 | 2015 | 232 | 0.120 |
Why?
| | Tobacco Products | 1 | 2013 | 55 | 0.120 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 440 | 0.120 |
Why?
| | Heat Shock Transcription Factors | 1 | 2011 | 14 | 0.120 |
Why?
| | Antioxidants | 2 | 2014 | 569 | 0.120 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 365 | 0.120 |
Why?
| | Metalloporphyrins | 1 | 2012 | 107 | 0.120 |
Why?
| | Promoter Regions, Genetic | 1 | 2017 | 1260 | 0.120 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 321 | 0.120 |
Why?
| | Bronchoalveolar Lavage | 1 | 2011 | 91 | 0.120 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2011 | 87 | 0.110 |
Why?
| | Adaptive Immunity | 1 | 2013 | 174 | 0.110 |
Why?
| | Cartilage, Articular | 1 | 2015 | 284 | 0.110 |
Why?
| | Disease Susceptibility | 1 | 2013 | 356 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 908 | 0.110 |
Why?
| | Toll-Like Receptor 4 | 1 | 2013 | 378 | 0.100 |
Why?
| | Chimera | 1 | 2008 | 60 | 0.100 |
Why?
| | Radiation Protection | 1 | 2008 | 36 | 0.090 |
Why?
| | Dendritic Cells | 1 | 2012 | 489 | 0.090 |
Why?
| | Lead | 1 | 2008 | 71 | 0.090 |
Why?
| | Models, Animal | 1 | 2009 | 393 | 0.090 |
Why?
| | Bone Marrow | 1 | 2008 | 284 | 0.080 |
Why?
| | Antibody Formation | 1 | 2008 | 299 | 0.080 |
Why?
| | Immunoglobulin E | 1 | 2008 | 355 | 0.080 |
Why?
| | Immunization | 1 | 2008 | 396 | 0.080 |
Why?
| | Lymph Nodes | 1 | 2008 | 484 | 0.070 |
Why?
| | Receptors, Drug | 1 | 2004 | 17 | 0.070 |
Why?
| | Caenorhabditis elegans | 1 | 2009 | 369 | 0.070 |
Why?
| | Potassium Channels, Inwardly Rectifying | 1 | 2004 | 33 | 0.070 |
Why?
| | Male | 4 | 2021 | 60715 | 0.070 |
Why?
| | Immunoglobulin G | 1 | 2008 | 787 | 0.070 |
Why?
| | Potassium Channels | 1 | 2004 | 133 | 0.070 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2004 | 129 | 0.070 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1651 | 0.070 |
Why?
| | Signal Transduction | 2 | 2019 | 4914 | 0.060 |
Why?
| | Mice, Inbred BALB C | 2 | 2018 | 1326 | 0.060 |
Why?
| | beta-N-Acetylhexosaminidases | 1 | 2021 | 10 | 0.060 |
Why?
| | Th1-Th2 Balance | 1 | 2021 | 11 | 0.060 |
Why?
| | Chitinases | 1 | 2021 | 9 | 0.060 |
Why?
| | CD11 Antigens | 1 | 2021 | 34 | 0.060 |
Why?
| | Cell Size | 1 | 2021 | 88 | 0.060 |
Why?
| | Lectins | 1 | 2021 | 54 | 0.060 |
Why?
| | CD11b Antigen | 1 | 2021 | 72 | 0.060 |
Why?
| | Asthma | 1 | 2012 | 1902 | 0.050 |
Why?
| | Phagocytosis | 1 | 2021 | 386 | 0.050 |
Why?
| | Eosinophils | 1 | 2021 | 267 | 0.050 |
Why?
| | HEK293 Cells | 1 | 2019 | 662 | 0.040 |
Why?
| | Gene Expression | 1 | 2021 | 1578 | 0.040 |
Why?
| | Neutrophils | 1 | 2021 | 1322 | 0.040 |
Why?
| | Sepharose | 1 | 2014 | 33 | 0.040 |
Why?
| | Female | 2 | 2021 | 62624 | 0.030 |
Why?
| | Glycine | 1 | 2014 | 152 | 0.030 |
Why?
| | Arginine | 1 | 2014 | 249 | 0.030 |
Why?
| | Heparin | 1 | 2014 | 210 | 0.030 |
Why?
| | Doxycycline | 1 | 2012 | 52 | 0.030 |
Why?
| | Osteoarthritis | 1 | 2015 | 168 | 0.030 |
Why?
| | Bone and Bones | 1 | 2015 | 251 | 0.030 |
Why?
| | Running | 1 | 2015 | 223 | 0.030 |
Why?
| | Knee Joint | 1 | 2015 | 295 | 0.030 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2014 | 655 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 797 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2015 | 775 | 0.030 |
Why?
| | Cotinine | 1 | 2009 | 64 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 2070 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2012 | 1184 | 0.020 |
Why?
| | RNA Interference | 1 | 2009 | 514 | 0.020 |
Why?
| | Nicotine | 1 | 2009 | 264 | 0.020 |
Why?
| | Time Factors | 1 | 2018 | 7054 | 0.020 |
Why?
| | Sulfonylurea Receptors | 1 | 2004 | 9 | 0.020 |
Why?
| | Hydrogen Bonding | 1 | 2004 | 154 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2012 | 2400 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2004 | 400 | 0.020 |
Why?
| | Risk Factors | 1 | 2014 | 8978 | 0.010 |
Why?
| | Models, Molecular | 1 | 2004 | 1603 | 0.010 |
Why?
|
|
Gally's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|